| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |